FDA Approvals

Date Posted
Article Title
8/14/2014
Belsomra Approved for Insomnia

First such drug designed to affect sleep-wake cycle

8/12/2014
Donor-Lung Preservation Device Approved

Technology may lead to more transplants, FDA says

8/12/2014
New Colorectal Cancer Screening Test Approved

Disease is the second-leading cause of cancer death in United States

8/7/2014
Orbactiv Approved for Drug-Resistant Skin Infections

Third such antibiotic sanctioned this year

8/1/2014
Jardiance Approved for Type 2 Diabetes

Blocks re-absorption of blood sugar by kidneys

7/31/2014
Once-Daily Inhaler Approved for COPD

Striverdi Respimat relaxes lung airways to improve breathing

7/28/2014
FDA Expands Use of Imbruvica for Form of Leukemia

People with CLL and a specific genetic anomaly can now get the therapy

7/24/2014
Tough-to-Abuse Formulation of Oxycodone Approved

Targiniq includes naloxone, which blocks euphoric effect if pill is crushed or broken

7/23/2014
Zydelig Approved for Three Types of Blood Cancer

But label warns drug may be toxic to liver

7/17/2014
Ruconest Approved for Rare Genetic Disease

Hereditary angioedema causes swelling of extremities, face and airways

7/3/2014
6/30/2014
6/23/2014
Sivextro Approved for Severe Skin Infections

Antibiotic can be injected or taken as a pill

6/13/2014
Lymphoseek Approved for Diagnosing Cancer Severity

Imaging agent helps determine if squamous cell has spread to head and neck

6/9/2014
6/2/2014
New Test Helps Doctors ID Kidney Disease Cause

Including autoimmune or infection

5/29/2014
Remote Monitoring Device Approved for Heart Patients

Measures pulmonary artery pressure and heart rate

5/27/2014
FDA Approves Antibiotic for Skin Infections

Dalvance (dalbavancin) should help against bacteria resistant to older drugs

5/20/2014
5/9/2014
Bionic Prosthetic Arm Approved

Helps amputees perform complex tasks by using signals from nearby muscles